CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

CLINICAL SIGNIFICANCE OF ASSESSMENT OF THROMBOSPONDIN AND PLACENTA GROWTH FACTOR LEVELS IN PATIENTS WITH SICKLE CELL ANEMIA: TWO CENTERS EGYPTIAN STUDIES

Abstract: Background: Sickle cell disease has a worldwide distribution. Vaso-occlusive crisis (VOC) is one of the most important clinical features of the disease. Thrombospondin (TSP1) and Placenta growth factor (PlGF) have been reported to be involved in sickle cell diseases (SCD). Objective: The...

Full description

Saved in:

Bibliographic Details
Main Authors:	adel abd elhaleim hagag, Ghada Elmashad, Aml Ezzat Abd El-Lateef
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-06-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Keywords: Sickle cell disease. Vaso-occlusive crisis. Placenta growth factor. Thrombospondin.
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/1391
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
by: SAGIR GUMEL AHMED
Published: (2011-01-01)

Sickle cell disease and Bartonella spp. infection
by: Paulo Eduardo Neves Ferreira Velho, et al.
Published: (2012-06-01)

A Longitudinal Analysis of Thrombin-Antithrombin Complex in Adult Sickle Cell Anemia during Vaso-occlusive Crisis and Steady State
by: Olateni Asake Adeoye, et al.
Published: (2025-04-01)

Sickle Cell Anemia Presenting with Vaso-Occlusive Pain: Should We Screen for COVID-19?
by: Mohammad Ali, et al.
Published: (2021-01-01)

Association of the SOD2 polymorphism (Val6Ala) and SOD activity with vaso-occlusive crisis and acute splenic sequestration in children with sickle cell anemia
by: Isabela Cristina Cordeiro Farias, et al.
Published: (2018-02-01)

Orthognathic surgery in a patient with sickle cell disease: A case report and review of literature
by: Hussain Albannai, et al.
Published: (2025-03-01)

Emergency Presentations of Pediatric Sickle Cell Disease in French Guiana
by: Carine Fankep Djomo, et al.
Published: (2025-05-01)

Polymorphic Distribution of Human Homeostatic Iron Regulator Gene H63D rs1799945 and Clinico‐Hematological Parameters of Sickle Cell Anemia Patients: A Case‐Control Study in Northern Ghana
by: Samuel Kwasi Appiah, et al.
Published: (2025-07-01)

LIVER DISEASE & SICKLE CELL DISEASE: AUTOIMMUNE HEPATITIS MORE THAN A COINCIDENCE; A SYSTEMATIC LITERATURE REVIEW.
by: Kelvin Lynch, et al.
Published: (2023-10-01)

The risk of pulmonary hypertension in sickle cell disease in relation to the disease severity
by: Salem Bahashwan
Published: (2025-01-01)

Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia
by: Romain Fort, et al.
Published: (2022-10-01)

Predictors and health impacts of Ramadan intermittent fasting among patients with sickle cell disease
by: Mortadah Hadi Alsalman, et al.
Published: (2025-05-01)

Postoperative acute multiple organ failure after hepatectomy in a Nigerian male with sickle cell trait: a case report
by: Toshimitsu Iwasaki, et al.
Published: (2021-01-01)

Role of sickling crisis with serum zinc in children with sickle cell anemia
by: Bahzad Khalid Sharaf, et al.
Published: (2022-06-01)

Nalbuphine as a Potential Alternative to Morphine in Sickle Cell Disease Patients with Vaso-occlusive Crisis: A Retrospective Cohort Study
by: Mohannad Alghamdi, et al.
Published: (2025-07-01)

Clinical Outcomes Among Patients With Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review
by: Nair R, et al.
Published: (2025-03-01)

Soluble immune checkpoint landscape in sickle cell disease links systemic inflammation, autoimmunity, and pain
by: Wei Li, et al.
Published: (2025-07-01)

Ten-year trends in opioid prescribing and vaso-occlusive crises in sickle cell disease: a population-based national cohort study (2011–2022)Research in context
by: Kevin Y. Xu, et al.
Published: (2025-10-01)

Case Report: Expanding the ocular horizon: subperiosteal orbital hematoma and Roth spots in known case of sickle cell disease
by: Rajvardhan Ravindra Patil, et al.
Published: (2025-06-01)

Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study
by: Shouq Turkistani, et al.
Published: (2025-06-01)

IMMUNOREGULATORY PROPERTIES OF THROMBOSPONDIN-1, A EXTRACELLULAR MATRIX COMPONENT AND ANGIOGENESIS INHIBITOR
by: S. A. Kuznetsova, et al.
Published: (2014-07-01)

Frequency of 11q23/MLL Gene Rearrangement in Egyptian Childhood Acute Myeloblastic Leukemia: Biologic and Clinical Significance
by: adel abd elhaleim hagag
Published: (2014-08-01)

Red Blood Cell Exchange Apheresis in the Management of Acute Chest Syndrome: Case Study at Greater Accra Regional Hospital (Ghana)‐ Bone Marrow Transplant Unit (BMT‐Ghana)
by: George Awuku Asare, et al.
Published: (2025-05-01)

A novel red blood cell deformability biomarker is associated with hemolysis and vaso-occlusive crises in sickle cell disease
by: Maxime Sahun, et al.
Published: (2025-05-01)

PROGNOSTIC IMPACT OF NEUROPILIN-1 EXPRESSION IN EGYPTIAN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA
by: adel abd elhaleim hagag, et al.
Published: (2014-12-01)

Safety and efficacy of ketamine use in patients with vaso‐occlusive crisis: A systematic review and meta‐analysis
by: Ernesto Calderon Martinez, et al.
Published: (2024-12-01)

The mechanobiology of extracellular matrix: a focus on thrombospondins
by: Ying Zhao, et al.
Published: (2025-07-01)

Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States
by: Udeze C, et al.
Published: (2025-04-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-05-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-01-01)

Rapid and Sensitive Detection of Thrombospondin-2 Using Nanoparticle Sensors for Cancer Screening and Prognosis
by: Maziyar Kalateh Mohammadi, et al.
Published: (2025-03-01)

A feasibility study of risk prediction modelling for vasoocclusive crisis in children with sickle cell disease
by: Merve Türkegün Şengül, et al.
Published: (2022-04-01)

The research progress of thrombospondin type-1 domain 7A and its antibodies in idiopathic membranous nephropathy
by: LI Jun, et al.
Published: (2019-01-01)

PROTECTIVE ROLE OF SYLIMARIN ON METHOTREXATE INDUCED HEPATO-NEPHROTOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Adel Abd Elhaleim Hagag
Published: (2016-09-01)

Thrombospondin-1 induces CD8+ T cell exhaustion and immune suppression within the tumor microenvironment of ovarian cancer
by: Haiyan Liang, et al.
Published: (2025-05-01)

Correlation between Nephropathy and Ophthalmic Complications in Cases of Sickle Cell Anemia: An Entangled Association
by: Aditi Pareek, et al.
Published: (2019-04-01)

Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis
by: Yu Huang, et al.
Published: (2021-04-01)

PROGNOSTIC IMPACT OF WT-1 GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Adel Abd Elhaleim Hagag
Published: (2016-01-01)

PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA
by: adel abd elhaleim hagag
Published: (2015-04-01)

Prophylactic internal iliac artery balloon occlusion in the management of placenta accreta spectrum disorders: a meta-analysis
by: Nicole dos Santos Pimenta, et al.
Published: (2025-06-01)